| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 25.817 | 37.688 | 44.760 | 17.376 | 4.890 | 35.385 | 62.386 | 58.209 |
| Total Income - EUR | - | - | 25.817 | 37.688 | 44.760 | 17.376 | 4.890 | 35.385 | 63.072 | 58.209 |
| Total Expenses - EUR | - | - | 1.102 | 9.765 | 10.426 | 9.724 | 6.294 | 7.957 | 19.936 | 21.909 |
| Gross Profit/Loss - EUR | - | - | 24.715 | 27.923 | 34.335 | 7.652 | -1.404 | 27.428 | 43.136 | 36.300 |
| Net Profit/Loss - EUR | - | - | 24.457 | 27.546 | 33.887 | 7.495 | -1.452 | 27.075 | 42.506 | 34.554 |
| Employees | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Embrio-Clinic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 219 | 0 | 0 | 991 | 671 | 374 | 74.053 | 69.946 |
| Current Assets | - | - | 26.157 | 31.495 | 36.625 | 14.114 | 6.880 | 28.915 | 42.349 | 10.273 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 3.395 | 20.129 | 15.080 | 259 | 1.430 | 17.400 | 26.870 | 0 |
| Cash | - | - | 22.761 | 11.366 | 21.545 | 13.854 | 5.449 | 11.516 | 15.479 | 10.273 |
| Shareholders Funds | - | - | 24.501 | 27.598 | 33.937 | 7.544 | -1.404 | 25.666 | 42.554 | 34.602 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.875 | 3.897 | 2.687 | 7.561 | 8.954 | 3.623 | 73.848 | 45.617 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Embrio-Clinic Srl